1. Home
  2. HWBK vs CNTX Comparison

HWBK vs CNTX Comparison

Compare HWBK & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HWBK

Hawthorn Bancshares Inc.

HOLD

Current Price

$37.00

Market Cap

253.0M

Sector

Finance

ML Signal

HOLD

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$1.48

Market Cap

283.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWBK
CNTX
Founded
1865
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.0M
283.9M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
HWBK
CNTX
Price
$37.00
$1.48
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.60
AVG Volume (30 Days)
3.8K
691.6K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
2.49%
N/A
EPS Growth
31.42
17.39
EPS
0.83
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$44.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.07
$0.56
52 Week High
$37.30
$3.62

Technical Indicators

Market Signals
Indicator
HWBK
CNTX
Relative Strength Index (RSI) 56.67 30.22
Support Level $34.49 $1.39
Resistance Level N/A $1.55
Average True Range (ATR) 0.86 0.22
MACD 0.02 -0.11
Stochastic Oscillator 78.87 4.97

Price Performance

Historical Comparison
HWBK
CNTX

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company that, along with its subsidiary bank, provides commercial banking for small and mid sized businesses, including equipment, operating, commercial real estate and SBA loans, and personal banking services such as real estate mortgage lending, installment and consumer loans, certificates of deposit, and checking, savings and money market accounts. It has two segments, banking and wealth management, with the banking segment earning the majority of its revenue and conducting general banking business, offering checking and savings accounts, internet banking, debit cards, certificates of deposit, brokerage services and others. Its primary source of revenue is net interest income derived from lending and deposit taking activities.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: